Author

Jart A. F. Oosterhaven

Observed names: J.A.F Oosterhaven, J.A.F. Oosterhaven, Jart A F Oosterhaven, Jart A.F. Oosterhaven, Jart Ate Franke Oosterhaven, Jart Oosterhaven, Oosterhaven, J. A.; id_orcid 0000-0001-7214-7528, Oosterhaven, Jart A F, Oosterhaven, Jart; id_orcid 0000-0001-7214-7528

Institutions: University Medical Center Groningen, University of Groningen

Observed institutions: University Medical Center Groningen, University of Groningen

ORCID: 0000-0001-7214-7528

Observed ORCID: 0000-0001-7214-7528

OpenAlex ID: A5081922548

Guidelines for diagnosis, prevention, and treatment of hand eczema

2021 · Jacob P. Thyssen, Marie L. A. Schuttelaar, et al. · Contact Dermatitis · 283

Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study

2019 · Jart A.F. Oosterhaven, Angelique N. Voorberg, et al. · The Journal of Dermatology · 70

Systematic review of cost‐of‐illness studies in hand eczema

2016 · Klaziena Politiek, Jart A. F. Oosterhaven, et al. · Contact Dermatitis · 69

European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis

2018 · Jart A. F. Oosterhaven, Wolfgang Uter, et al. · Contact Dermatitis · 51

Responsiveness and interpretability of the Hand Eczema Severity Index

2019 · J.A.F. Oosterhaven, M.L.A. Schuttelaar · British Journal of Dermatology · 42

Vesicular hand eczema transcriptome analysis provides insights into its pathophysiology

2021 · Angelique N. Voorberg, Hanna Niehues, et al. · Experimental Dermatology · 30

Presenteeism in a Dutch hand eczema population—a cross‐sectional survey

2018 · Jart A. F. Oosterhaven, Peter A. Flach, et al. · Contact Dermatitis · 29

Dupilumab Treatment of Very Severe Refractory Atopic Hand Eczema

2018 · Jart A. F. Oosterhaven, Geertruida L. E. Romeijn, et al. · JAMA Dermatology · 28

Which outcomes have been measured in hand eczema trials? A systematic review

2019 · Henriette Rönsch, Christian Apfelbacher, et al. · Contact Dermatitis · 26

Azathioprine treatment and drug survival in patients with chronic hand eczema – results from daily practice

2017 · Jart A. F. Oosterhaven, Klaziena Politiek, et al. · Contact Dermatitis · 22

Interpretability of the Quality Of Life in Hand Eczema Questionnaire

2019 · Jart A.F. Oosterhaven, Robert F. Ofenloch, et al. · Journal of Investigative Dermatology · 20

Validation of the Dutch Quality of Life in Hand Eczema Questionnaire ( QOLHEQ )

2019 · J.A.F. Oosterhaven, R.F. Ofenloch, et al. · British Journal of Dermatology · 20

Cross-Cultural Validation of the Quality of Life in Hand Eczema Questionnaire (QOLHEQ)

2017 · Robert F. Ofenloch, Jart A.F. Oosterhaven, et al. · Journal of Investigative Dermatology · 20

Guideline for translation and national validation of the Q uality of L ife in H and E czema Q uestionnaire ( QOLHEQ )

2017 · Jart A. F. Oosterhaven, Marie L. A. Schuttelaar, et al. · Contact Dermatitis · 15

Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab – a cross-sectional study from the BioDay registry

2021 · Jart A. F. Oosterhaven, Lotte S. Spekhorst, et al. · Journal of Dermatological Treatment · 14

Validity, reliability, responsiveness and interpretability of the Recap of atopic eczema (RECAP) questionnaire

2023 · Junfen Zhang, Aviël Ragamin, et al. · British Journal of Dermatology · 13

Efficacy and safety of oral alitretinoin versus oral azathioprine in patients with severe chronic hand eczema: Results from a prematurely discontinued randomized controlled trial

2022 · Angelique N. Voorberg, Esmé Kamphuis, et al. · Contact Dermatitis · 13

Hand eczema among Dutch beekeepers – a cross‐sectional study

2019 · Jart A. F. Oosterhaven, Julia Verbist, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 11

Results of patch testing in Indonesian shoe factory workers

2016 · J.A.F. Oosterhaven, S.A. Febriana, et al. · Journal of the European Academy of Dermatology and Venereology · 10

The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in children

2024 · Aviël Ragamin, Junfen Zhang, et al. · British Journal of Dermatology · 9

Content validity of the Recap of atopic eczema (RECAP) instrument in Dutch, English and German to measure eczema control in young people with atopic eczema: a cognitive interview study

2022 · Michaela Gabes, Aviël Ragamin, et al. · British Journal of Dermatology · 9

Study protocol: efficacy of oral alitretinoin versus oral cyclosporine A in patients with severe recurrent vesicular hand eczema (ALICsA): a randomised prospective open-label trial with blinded outcome assessment

2018 · Jart Ate Franke Oosterhaven, Marie Louise Anna Schuttelaar · BMJ Open · 7

Is there an increased risk of cervical neoplasia in atopic dermatitis patients treated with oral immunosuppressive drugs?

2017 · F.M. Garritsen, R.H.M. Verheijen, et al. · Journal of the European Academy of Dermatology and Venereology · 7

EDP ‐297: A novel, farnesoid X receptor agonist—Results of a phase I study in healthy subjects

2022 · Christine Marotta, Alaa Ahmad, et al. · Clinical and Translational Science · 4

Evidence-Based Management of Hand Eczema

2019 · Marie Louise A. Schuttelaar, Jart A. F. Oosterhaven, et al. · Springer eBooks · 4

Works count: 49

Citation count: 840

H-index: 14

I10-index: 19